Completed PHASE4 INTERVENTIONAL NCT00000455

Naltrexone for Early Problem Drinkers

Targeted Naltrexone for Early Problem Drinkers

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Interventions naltrexone

Updated 5 times since 2017 Last updated: Jun 17, 2011 Completion: Sep 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000455, this PHASE4 trial focuses on Alcoholism and remains completed. Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
UConn Health

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States